Proficio Capital Partners LLC Acquires Shares of 25,500 VanEck Biotech ETF $BBH

Proficio Capital Partners LLC bought a new position in VanEck Biotech ETF (NASDAQ:BBH) in the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm bought 25,500 shares of the company’s stock, valued at approximately $5,183,000. Proficio Capital Partners LLC owned 1.31% of VanEck Biotech ETF at the end of the most recent reporting period.

Several other institutional investors have also made changes to their positions in the company. Nwam LLC acquired a new stake in shares of VanEck Biotech ETF during the second quarter valued at approximately $18,614,000. JNBA Financial Advisors acquired a new position in VanEck Biotech ETF in the 2nd quarter worth approximately $122,000. Headlands Technologies LLC acquired a new position in VanEck Biotech ETF in the 2nd quarter worth approximately $1,576,000. Quantitative Investment Management LLC purchased a new position in VanEck Biotech ETF during the 2nd quarter worth approximately $7,589,000. Finally, Segall Bryant & Hamill LLC purchased a new position in VanEck Biotech ETF during the 1st quarter worth approximately $881,000. 32.05% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling at VanEck Biotech ETF

In other news, major shareholder Sardar Biglari sold 6,533 shares of VanEck Biotech ETF stock in a transaction on Wednesday, July 15th. The stock was sold at an average price of $16.71, for a total transaction of $109,166.43. Following the transaction, the insider owned 3,552,710 shares in the company, valued at approximately $59,365,784.10. The trade was a 0.18% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Insiders sold a total of 10,493 shares of company stock worth $175,335 in the last quarter.

VanEck Biotech ETF Price Performance

Shares of NASDAQ:BBH opened at $235.50 on Tuesday. The company’s fifty day moving average is $213.87 and its two-hundred day moving average is $197.38. VanEck Biotech ETF has a 12-month low of $160.91 and a 12-month high of $244.35.

VanEck Biotech ETF Profile

The BIOTECH HOLDING COMPANY DEPOSITARY RECEIPTS or HOLDRS TRUST was formed under the depositary trust agreement, among The Bank of New York, as trustee, Merrill Lynch, Pierce, Fenner & Smith Incorporated, other depositors and the owners of the Biotech HOLDRS. The trust currently holds shares of common stock or American depositary shares issued by a group of companies that were, at the time of the initial offering, generally considered to be involved in various segments of thebiotechnology industry.